Peptides for Longevity
Peptides associated with cellular health, mitochondrial function, and age-related physiological pathways. Evidence ranges from early-stage to investigational.
Educational content only. The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making decisions about any medication or health intervention. Regulations and product availability vary by country and jurisdiction. Learn about peptide safety & regulation →
GHK-Cu
Glycyl-L-Histidyl-L-Lysine Copper
GHK-Cu is a naturally occurring copper-binding tripeptide researched for collagen synthesis and wound healing. Topical forms appear in many cosmetic products; injectable use is not FDA-approved.
CJC-1295
GHRH Analog (with DAC)
CJC-1295 is a GHRH analog that stimulates pituitary GH release. Limited human clinical data exists; it is not FDA-approved and is classified as a compounding safety concern.
Ipamorelin
GHS-R1a Agonist (selective)
Ipamorelin is a selective growth hormone secretagogue that triggers pulsatile GH release without significant cortisol or prolactin elevation. Not FDA-approved; WADA-prohibited.
Sermorelin
GRF 1-29 / GHRH 1-29
Sermorelin (GHRH 1-29) was previously FDA-approved for pediatric GH deficiency and is now available through compounding. It stimulates pituitary GH release and has a longer clinical history than most research peptides.
Tesamorelin
Egrifta / Egrifta WR
Tesamorelin (Egrifta) is an FDA-approved GHRH analog indicated for HIV-associated lipodystrophy. It stimulates endogenous GH release and has Phase 3 trial data supporting its approved use.
Compare prices and lab grades
Use our price comparison and Finnrick lab data tools alongside this guide.